Positively selected enhancer elements endow osteosarcoma cells with metastatic competence

The Sequence Alignment/Map format and SAMtools

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · see citing works

Model-based Analysis of ChIP-Seq (MACS)

Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386 · see citing works

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556 · see citing works

TopHat: discovering splice junctions with RNA-Seq

Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,477 · see citing works

GREAT improves functional interpretation of cis-regulatory regions

McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502 · see citing works

Selective inhibition of BET bromodomains

Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · see citing works

Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143 · see citing works

Tumor Metastasis: Molecular Insights and Evolving Paradigms

Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011 · see citing works

Dissemination and growth of cancer cells in metastatic sites

Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature reviews. Cancer · doi:10.1038/nrc865 · Cited by 3,920 · see citing works

Super-enhancers in the control of cell identity and disease

Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · see citing works

Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences

Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,437 · see citing works

Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · see citing works

Genes that mediate breast cancer metastasis to lung

Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · see citing works

Tumour evolution inferred by single-cell sequencing

Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598 · see citing works

A multigenic program mediating breast cancer metastasis to bone

Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,562 · see citing works

Histone modifications at human enhancers reflect global cell-type-specific gene expression

Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., et al. (2009) · Nature · doi:10.1038/nature07829 · Cited by 2,533 · see citing works

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502 · see citing works

A molecular signature of metastasis in primary solid tumors

Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2002) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,448 · see citing works

Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation

Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013984 · Cited by 2,235 · see citing works

A unique chromatin signature uncovers early developmental enhancers in humans

Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S. A., Flynn, R. A., & Wysocka, J. (2011) · Nature · doi:10.1038/nature09692 · Cited by 2,233 · see citing works

Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting

Čermák, T., Doyle, E., Christian, M. L., Wang, L., Zhang, Y., Schmidt, C. L., Baller, J. A., Somia, N. V., Bogdanove, A. J., & Voytas, D. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr218 · Cited by 2,034 · see citing works

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863 · see citing works

The evolutionary history of lethal metastatic prostate cancer

ICGC Prostate UK Group, Gundem, G., Loo, P. V., Kremeyer, B., Alexandrov, L. B., Tubío, J. M. C., Papaemmanuil, E., Brewer, D. S., Kallio, H. M. L., Högnäs, G., et al. (2015) · Nature · doi:10.1038/nature14347 · Cited by 1,358 · see citing works

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317 · see citing works

Translational biology of osteosarcoma

Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294 · see citing works

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,163 · see citing works

An Abundance of Ubiquitously Expressed Genes Revealed by Tissue Transcriptome Sequence Data

Ramsköld, D., Wang, E. T., Burge, C. B., & Sandberg, R. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000598 · Cited by 820 · see citing works

Comparative lesion sequencing provides insights into tumor evolution

Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 817 · see citing works

An Optimized microRNA Backbone for Effective Single-Copy RNAi

Fellmann, C., Hoffmann, T., Sridhar, V., Hopfgartner, B., Muhar, M., Roth, M., Lai, D. Y., Barbosa, I. A. M., Kwon, J. S., Guan, Y., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.020 · Cited by 705 · see citing works

Cistrome: an integrative platform for transcriptional regulation studies

Liu, T., Ortiz, J. A., Taing, L., Meyer, C. A., Lee, B. T. K., Zhang, Y., Shin, H., Wong, S. S., Ma, J., Lei, Y., et al. (2011) · Genome biology · doi:10.1186/gb-2011-12-8-r83 · Cited by 705 · see citing works

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., Chen, L., Ewing, C. M., Eisenberger, M. A., Carducci, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1944 · Cited by 655 · see citing works

Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

Puissant, A., Frumm, S. M., Alexe, G., Bassil, C. F., Qi, J., Chanthery, Y. H., Nekritz, E. A., Zeid, R., Gustafson, W. C., Greninger, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0418 · Cited by 637 · see citing works

DNase-seq: A High-Resolution Technique for Mapping Active Gene Regulatory Elements across the Genome from Mammalian CellsPreprint

Song, L., & Crawford, G. E. (2010) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot5384 · Cited by 625 · see citing works

Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions

Zentner, G. E., Tesar, P. J., & Scacheri, P. C. (2011) · Genome Research · doi:10.1101/gr.122382.111 · Cited by 564 · see citing works

Genome-wide chromatin state transitions associated with developmental and environmental cues

Zhu, J., Adli, M., Zou, J., Verstappen, G., Coyne, M. J., Zhang, X.-L., Durham, T. J., Miri, M., Deshpande, V., Jager, P. D., et al. (2013) · Cell · doi:10.1016/j.cell.2012.12.033 · Cited by 553 · see citing works

ChIP-seq: Using high-throughput sequencing to discover protein–DNA interactions

Schmidt, D., Wilson, M. D., Spyrou, C., Brown, G. D., Hadfield, J., & Odom, D. T. (2009) · Methods · doi:10.1016/j.ymeth.2009.03.001 · Cited by 515 · see citing works

g:Profiler—a web server for functional interpretation of gene lists (2011 update)

Reimand, J., Arak, T., & Vilo, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr378 · Cited by 504 · see citing works

Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis

McDonald, O. G., Li, X., Saunders, T., Tryggvadottir, R., Mentch, S. J., Warmoes, M. O., Word, A. E., Carrer, A., Salz, T. H., Natsume, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3753 · Cited by 494 · see citing works

Targeting the ANGPT–TIE2 pathway in malignancy

Huang, H., Bhat, A., Woodnutt, G., & Lappe, R. W. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2894 · Cited by 464 · see citing works

Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis

Roe, J., Hwang, C., Somerville, T. D. D., Milazzo, J. P., Lee, E. J., Silva, B. D., Maiorino, L., Tiriac, H., Young, C. M., Miyabayashi, K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.007 · Cited by 458 · see citing works

Transcriptional and Epigenetic Dynamics during Specification of Human Embryonic Stem Cells

Gifford, C. A., Ziller, M. J., Gu, H., Trapnell, C., Donaghey, J., Tsankov, A., Shalek, A. K., Kelley, D. R., Shishkin, A. A., Issner, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.037 · Cited by 435 · see citing works

Robust 4C-seq data analysis to screen for regulatory DNA interactions

van de Werken, H. J. G., Landan, G., Holwerda, S. J. B., Hoichman, M., Klous, P., Chachik, R., Splinter, E., Valdes‐Quezada, C., Öz, Y., Bouwman, B. A. M., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2173 · Cited by 376 · see citing works

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer

Hong, M. K. H., Macintyre, G., Wedge, D. C., Loo, P. V., Patel, K., Lunke, S., Alexandrov, L. B., Sloggett, C., Cmero, M., Marass, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms7605 · Cited by 367 · see citing works

Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits

Corradin, O., Saiakhova, A., Akhtar-Zaidi, B., Myeroff, L., Willis, J., Cowper-Sal·lari, R., Lupien, M., Markowitz, S., & Scacheri, P. C. (2014) · Genome Research · doi:10.1101/gr.164079.113 · Cited by 366 · see citing works

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk

Clayton, P., Banerjee, I., Murray, P. G., & Renehan, A. G. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.171 · Cited by 362 · see citing works

Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility

Denny, S. K., Yang, D., Chuang, C.-H., Brady Jennifer, J., Lim, J. S., Grüner, B. M., Chiou, S., Schep, A. N., Baral, J., Hamard, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.052 · Cited by 358 · see citing works

BET Bromodomain Inhibition of MYC -Amplified Medulloblastoma

Bandopadhayay, P., Bergthold, G., Nguyen, B., Schubert, S., Gholamin, S., Tang, Y., Bolin, S., Schumacher, S. E., Zeid, R., Masoud, S. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2281 · Cited by 356 · see citing works

The relationship between tissue factor and cancer progression: insights from bench and bedside

van den Berg, Y. W., Osanto, S., Reitsma, P. H., & Versteeg, H. H. (2011) · Blood · doi:10.1182/blood-2011-06-317685 · Cited by 354 · see citing works

Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer

Akhtar‐Zaidi, B., Sallari, R. C., Corradin, O., Saiakhova, A., Bartels, C. F., Balasubramanian, D., Myeroff, L. L., Lutterbaugh, J., Jarrar, A., Kalady, M. F., et al. (2012) · Science · doi:10.1126/science.1217277 · Cited by 337 · see citing works

Inhibition of tissue factor signaling suppresses tumor growth

Versteeg, H. H., Schaffner, F., Kerver, M., Petersen, H. H., Ahamed, J., Felding‐Habermann, B., Takada, Y., Mueller, B. M., & Ruf, W. (2007) · Blood · doi:10.1182/blood-2007-07-101048 · Cited by 327 · see citing works

Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi

Zuber, J., McJunkin, K., Fellmann, C., Dow, L. E., Taylor, M. J., Hannon, G., & Lowe, S. (2010) · Nature Biotechnology · doi:10.1038/nbt.1720 · Cited by 277 · see citing works

An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential

Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., & Helman, L. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006767007547 · Cited by 207 · see citing works

Efficient TALEN construction and evaluation methods for human cell and animal applications

Sakuma, T., Hosoi, S., Woltjen, K., Suzuki, K., Kashiwagi, K., Wada, H., Ochiai, H., Miyamoto, T., Kawai, N., Sasakura, Y., et al. (2013) · Genes to Cells · doi:10.1111/gtc.12037 · Cited by 202 · see citing works

Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition

Latil, M., Nassar, D., Beck, B., Boumahdi, S., Wang, L., Brisebarre, A., Dubois, C., Nkusi, E., Lenglez, S., Chęcińska, A., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.10.018 · Cited by 197 · see citing works

Epigenomic Comparison Reveals Activation of “Seed” Enhancers during Transition from Naive to Primed Pluripotency

Factor, D. C., Corradin, O., Zentner, G. E., Saiakhova, A., Song, L., Chenoweth, J. G., McKay, R. D. G., Crawford, G. E., Scacheri, P. C., & Tesar, P. J. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.05.005 · Cited by 159 · see citing works

Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle

Lamoureux, F., Baud’huin, M., Calleja, L. R., Jacques, C., Berreur, M., Rédiní, F., Lecanda, F., Bradner, J. E., Heymann, D., & Ory, B. (2014) · Nature Communications · doi:10.1038/ncomms4511 · Cited by 148 · see citing works

Possible epigenetic mechanisms of tumor progression: Induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment

Kerbel, R. S., Frost, P., Liteplo, R. G., Carlow, D. A., & Elliott, B. E. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210411 · Cited by 125 · see citing works

Characterization of the metastatic phenotype of a panel of established osteosarcoma cells

Ren, L., Mendoza, A., Zhu, J., Briggs, J., Halsey, C., Hong, E. S., Burkett, S. S., Morrow, J. J., Lizardo, M. M., Osborne, T. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5177 · Cited by 119 · see citing works

Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1

Javaid, S., Zhang, J., Anderssen, E., Black, J. C., Wittner, B. S., Tajima, K., Ting, D. T., Smolen, G. A., Zubrowski, M. J., Desai, R. N., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.034 · Cited by 116 · see citing works

Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome

Cohen, A. J., Saiakhova, A., Corradin, O., Luppino, J. M., Lovrenert, K., Bartels, C. F., Morrow, J. J., Mack, S. C., Dhillon, G. K., Beard, L., et al. (2017) · Nature Communications · doi:10.1038/ncomms14400 · Cited by 116 · see citing works

A Computational Algorithm to Predict shRNA Potency

Knott, S., Maceli, A. R., Erard, N., Chang, K., Marran, K., Zhou, X., Gordon, A., Demerdash, O. E., Wagenblast, E., Kim, S. Y., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.025 · Cited by 96 · see citing works

Modeling metastasis biology and therapy in real time in the mouse lung

Mendoza, A., Hong, S.-H., Osborne, T., Khan, M. A., Campbell, K., Briggs, J., Eleswarapu, A., Buquo, L., Ren, L., Hewitt, S. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40252 · Cited by 92 · see citing works

Inhibition of Growth of Human Osteosarcomas by Antagonists of Growth Hormone-Releasing Hormone

Pinski, J., Schally, A. V., Groot, K., Halmos, G. B., Szepesházi, K., Zarándi, M., & Armatis, P. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.23.1787 · Cited by 91 · see citing works

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity

Li, N., Lee, K., Xi, Y., Zhu, B., Gary, B. D., Ramírez‐Alcántara, V., Gurpinar, E., Canzoneri, J. C., Fajardo, A., Sigler, S. C., et al. (2014) · Oncogene · doi:10.1038/onc.2014.94 · Cited by 72 · see citing works

Inhibition of AP-1 Transcriptional Activity Blocks the Migration, Invasion, and Experimental Metastasis of Murine Osteosarcoma

Leaner, V. D., Chick, J. F. B., Donninger, H., Linniola, I., Mendoza, A., Khanna, C., & Birrer, M. J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.071006 · Cited by 50 · see citing works

Epigenetic contributions to cancer metastasis

Rodenhiser, D. I. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9166-2 · Cited by 47 · see citing works

Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes

Moelans, C. B., van der Groep, P., Hoefnagel, L. D. C., van de Vijver, M. J., Wesseling, P., Wesseling, J., van der Wall, E., & van Diest, P. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.025 · Cited by 43 · see citing works

The Metastasectomy and Timing of Pulmonary Metastases on the Outcome of Osteosarcoma Patients

Huang, Y.-M., Hou, C., Hou, S., & Yang, R. (2009) · Clinical medicine Oncology · doi:10.4137/cmo.s531 · Cited by 40 · see citing works

Evaluation of eIF4E Expression in an Osteosarcoma-Specific Tissue Microarray

Osborne, T. S., Ren, L., Healey, J. H., Shapiro, L., Chou, A. J., Gorlick, R. G., Hewitt, S. M., & Khanna, C. (2011) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318223d0c1 · Cited by 25 · see citing works

Advancing therapy for osteosarcoma

Gill, J., & Gorlick, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00519-8 · Cited by 876 · see citing works

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works

The AP-1 transcriptional complex: Local switch or remote command?

Bejjani, F., Evanno, E., Zibara, K., Piechaczyk, M., & Jariel‐Encontre, I. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.003 · Cited by 355 · see citing works

Prostate cancer reactivates developmental epigenomic programs during metastatic progression

Pomerantz, M. M., Qiu, X., Zhu, Y., Takeda, D. Y., Pan, W., Baca, S. C., Gusev, A., Korthauer, K. D., Severson, T., Ha, G., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0664-8 · Cited by 266 · see citing works

Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy

Xie, X.-H. P., Laks, D., Sun, D., Ganbold, M., Wang, Z.-L., Pedraza, A. M., Bale, T., Tabar, V., Brennan, C. W., Zhou, X.-P., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2021.12.007 · Cited by 169 · see citing works

Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group

Roberts, R. D., Lizardo, M. M., Reed, D. R., Hingorani, P., Glover, J., Allen‐Rhoades, W., Fan, T., Khanna, C., Sweet‐Cordero, E. A., Cash, T., et al. (2019) · Cancer · doi:10.1002/cncr.32351 · Cited by 127 · see citing works

The Multifaceted Output of c-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and Exhaustion

Papavassiliou, A. G., & Musti, A. M. (2020) · Cells · doi:10.3390/cells9112470 · Cited by 122 · see citing works

Class I HDAC inhibitors enhance YB‐1 acetylation and oxidative stress to block sarcoma metastasis

El-Naggar, A. M., Somasekharan, S. P., Wang, Y., Cheng, H., Negri, G. L., Pan, M., Wang, X. Q., Delaidelli, A., Rafn, B., Cran, J., et al. (2019) · EMBO Reports · doi:10.15252/embr.201948375 · Cited by 113 · see citing works

In situ hydrogel based on Cu–Fe3O4 nanoclusters exploits oxidative stress and the ferroptosis/cuproptosis pathway for chemodynamic therapy

Zhang, Y., Zhang, N., Xing, J., Sun, Y., Xu, J., Shen, C., Cheng, L., Wang, Y., & Wang, X. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122675 · Cited by 115 · see citing works

Pharmacological Inhibition of Core Regulatory Circuitry Liquid–liquid Phase Separation Suppresses Metastasis and Chemoresistance in Osteosarcoma

Lu, B., Zou, C., Yang, M., He, Y., He, J., Zhang, C., Chen, S., Yu, J., Liu, K. Y., Cao, Q., et al. (2021) · Advanced Science · doi:10.1002/advs.202101895 · Cited by 95 · see citing works

SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes

Xie, Y., Şahin, M., Sinha, S., Wang, Y., Nargund, A. M., Lyu, Y., Han, S., Dong, Y., Hsieh, J. J.-D., Leslie, C. S., et al. (2022) · Nature Cancer · doi:10.1038/s43018-021-00316-3 · Cited by 94 · see citing works

Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression

Fan, T. M., Roberts, R. D., & Lizardo, M. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00013 · Cited by 90 · see citing works

Mapping genomic and epigenomic evolution in cancer ecosystems

Ushijima, T., Clark, S. J., & Tan, P. B. O. (2021) · Science · doi:10.1126/science.abh1645 · Cited by 88 · see citing works

Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling

Jeon, H.-M., Kim, J., Cho, H. J., Lee, W. J., Nguyen, D., Kim, S. S., Oh, Y. T., Kim, H., Jung, C., Piñero, G., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.06.007 · Cited by 89 · see citing works

The roles of epigenetics in cancer progression and metastasis

Chen, J. F.-Y., & Yan, Q. (2021) · Biochemical Journal · doi:10.1042/bcj20210084 · Cited by 88 · see citing works

Current Status and Prospects of Targeted Therapy for Osteosarcoma

Hu, Z., Wen, S., Huo, Z., Wang, Q., Zhao, J., Wang, Z., Chen, Y., Zhang, L., Zhou, F., Guo, Z., et al. (2022) · Cells · doi:10.3390/cells11213507 · Cited by 73 · see citing works

SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer

Perone, Y., Farrugia, A. J., Rodríguez-Meira, A., Győrffy, B., Ion, C., Uggetti, A., Chronopoulos, A., Marrazzo, P., Faronato, M., Shousha, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09676-y · Cited by 66 · see citing works

ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells

Sen, M., Wang, X., Hamdan, F. H., Rapp, J., Eggert, J., Kosinsky, R. L., Wegwitz, F., Kutschat, A. P., Younesi, F. S., Gaedcke, J., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0690-5 · Cited by 61 · see citing works

Genomic control of metastasis

Patel, S. A., Rodrigues, P., Wesolowski, L., & Vanharanta, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01127-6 · Cited by 58 · see citing works

Bone sarcomas in the immunotherapy era

Heymann, M., Schiavone, K., & Heymann, D. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14999 · Cited by 57 · see citing works

Treating osteosarcoma with CAR T cells

Köksal, H., Müller, E., Inderberg, E. M., Bruland, Ø. S., & Wälchli, S. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12741 · Cited by 56 · see citing works

Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma

Zhang, J., Liu, S., Ye, Q., & Pan, J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1070-7 · Cited by 56 · see citing works

Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis

Shi, Y., Gong, M., Deng, Z., Liu, H., Chang, Y., Yang, Z., & Cai, L. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.06.036 · Cited by 55 · see citing works

5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling

Singh, D. K., Carcamo, S., Farias, E., Hasson, D., Zheng, W., Sun, D., Huang, X., Cheung, J. F., Nobre, A. R., Kale, N., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112560 · Cited by 54 · see citing works

NF-κB–Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis

Rodrigues, P., Patel, S. A., Harewood, L., Olan, I., Vojtasova, E., Syafruddin, S. E., Zaini, M. N., Richardson, E. K., Burge, J., Warren, A. Y., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1211 · Cited by 53 · see citing works

Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma

Liao, Y., Yu, H., Lv, J., Cai, Y., Liu, F., He, Z., & He, S. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4902 · Cited by 53 · see citing works

Oncogenes and Clotting Factors: The Emerging Role of Tumor Cell Genome and Epigenome in Cancer-Associated Thrombosis

Tawil, N., Bassawon, R., & Rak, J. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1687891 · Cited by 44 · see citing works

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

Zhou, R. W., Xu, J., Martin, T. C., Zachem, A. L., He, J. C., Ozturk, S., Demircioğlu, D., Bansal, A., Trotta, A. P., Giotti, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33377-8 · Cited by 49 · see citing works

Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma

Bayles, I., Krajewska, M., Pontius, W. D., Saiakhova, A., Morrow, J. J., Bartels, C., Lu, J., Faber, Z. J., Fedorov, Y., Hong, E. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127718 · Cited by 46 · see citing works

Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits

Choudhuri, A., Trompouki, E., Abraham, B. J., Colli, L. M., Kock, K. H., Mallard, W., Yang, M.-L., Vinjamur, D. S., Ghamari, A., Sporrij, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00738-2 · Cited by 44 · see citing works

Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer

Liu, J., Jia, J., Wang, S., Zhang, J., Xian, S., Zheng, Z., Deng, L., Deng, L., Zhang, Y., & Zhang, Y. (2022) · Molecules · doi:10.3390/molecules27134108 · Cited by 46 · see citing works

Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

Schott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0873 · Cited by 45 · see citing works

Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas

Unruh, D. J., Mirkov, S., Wray, B. D., Drumm, M. R., Lamano, J. B., Li, Y. D., Haider, Q. F., Javier, R., McCortney, K., Saratsis, A. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1222 · Cited by 44 · see citing works

An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields

Beyes, S., Bediaga, N. G., & Zippo, A. (2021) · Cancers · doi:10.3390/cancers13194969 · Cited by 42 · see citing works

Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma

Lietz, C. E., Newman, E. T., Kelly, A. D., Xiang, D. H., Zhang, Z., Luscko, C. A., Lozano‐Calderón, S. A., Ebb, D. H., Raskin, K. A., Cote, G. M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03117-1 · Cited by 42 · see citing works

Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: Recent advancements

Adewuyi, E. E., Chorya, H. P., Muili, A. O., Moradeyo, A. A., Kayode, A. T., Naik, A., Odedele, J. T., & Obasanjo, O. M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104575 · Cited by 42 · see citing works

Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression

Chen, J., Qian, C., Ren, P., Han, Y., Kong, X., Huang, C., Luo, H., & Chen, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.679610 · Cited by 43 · see citing works

Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model

Mazumdar, A., Urdinez, J., Boro, A., Arlt, M. J. E., Egli, F. E., Niederöst, B., Jaeger, P. K., Moschini, G., Muff, R., Fuchs, B., et al. (2020) · Cancers · doi:10.3390/cancers12113457 · Cited by 40 · see citing works

Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway

Wang, R., Liu, W., Wang, Q., Li, G., Wan, B., Sun, Y., Niu, X., Chen, D., & Tian, W. (2020) · Biomaterials Science · doi:10.1039/d0bm00898b · Cited by 40 · see citing works

Prognostic value of tumoral and peritumoral magnetic resonance parameters in osteosarcoma patients for monitoring chemotherapy response

Hao, Y., An, R. F., Xue, Y., Li, F., Wang, H., Zheng, J., Fan, L., Liu, J., Fan, H., & Yin, H. J. (2020) · European Radiology · doi:10.1007/s00330-020-07338-y · Cited by 39 · see citing works

Osteosarcoma tumor microenvironment: the key for the successful development of biologically relevant 3D in vitro models

Rodrigues, J., Sarmento, B. F. C. C., & Pereira, C. L. (2022) · In vitro models · doi:10.1007/s44164-022-00008-x · Cited by 39 · see citing works

Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain

Cai, W. L., Greer, C. B., Chen, J. F.-Y., Estape, A. A., Cao, J. P., Yan, Q., & Nguyen, D. X. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0695-0 · Cited by 36 · see citing works

Platelet-Derived TGF-β Induces Tissue Factor Expression via the Smad3 Pathway in Osteosarcoma Cells

Saito, M., Ichikawa, J., Ando, T., Schoenecker, J. G., Ohba, T., Koyama, K., Suzuki‐Inoue, K., & Haro, H. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3537 · Cited by 34 · see citing works

Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies

Schott, C. R., Shah, A. T., & Sweet-Cordero, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_1 · Cited by 30 · see citing works

CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition

Liao, Y., Lv, J., Zhou, Z., Xu, T.-Y., Dong, Y., Gao, Q., Fan, L., Li, G., Yu, H., & Liu, K.-Y. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5229 · Cited by 30 · see citing works

Recent Advances in Pediatric Cancer Research

McEachron, T. A., & Helman, L. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1191 · Cited by 33 · see citing works

EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma

Apfelbaum, A. A., Wu, F., Hawkins, A. G., Magnuson, B., Jiménez, J. A., Taylor, S. D., Wrenn, E. D., Waltner, O. G., Pfaltzgraff, E. R., Song, J. Y., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0384 · Cited by 31 · see citing works

Enzyme-induced morphological transformation of self-assembled peptide nanovehicles potentiates intratumoral aggregation and inhibits tumour immunosuppression

Cao, J., Liu, X., Yuan, X., Meng, F., Sun, X., Xu, L., Li, H., Liu, Y., Hong, Z., & Bai, J. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140466 · Cited by 30 · see citing works

Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma

Guo, W., Wang, X., Lu, B., Yu, J., Xu, M., Huang, R., Cheng, M., Yang, M., Zhao, W., & Zou, C. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05966-y · Cited by 29 · see citing works

Etiology of super-enhancer reprogramming and activation in cancer

Zhou, R. W., & Parsons, R. E. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00502-w · Cited by 30 · see citing works

Sarcoma as a Model for Adolescent and Young Adult Care

Reed, D. R., Naghavi, A. O., & Binitie, O. T. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00684 · Cited by 27 · see citing works

Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting

Rosell, A., Moser, B., Hisada, Y., Chinthapatla, R., Lian, G., Yang, Y., Flick, M. J., & Mackman, N. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12363 · Cited by 26 · see citing works

223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy

Anderson, P. M., Scott, J. G., Parsai, S., Zahler, S. G., Worley, S. E., Shrikanthan, S., Subbiah, V., & Murphy, E. S. (2020) · ESMO Open · doi:10.1136/esmoopen-2019-000635 · Cited by 24 · see citing works

Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis

Ando, T., Ichikawa, J., Fujimaki, T., Taniguchi, N., Takayama, Y., & Haro, H. (2020) · Cancers · doi:10.3390/cancers12113097 · Cited by 23 · see citing works

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma

Yu, M., Qian, K., Wang, G., Xiao, Y., Zhu, Y., & Ju, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1114461 · Cited by 23 · see citing works

Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs

Silver, K. I., Patkar, S., Mazcko, C. N., Berger, E. P., Beck, J. A., & LeBlanc, A. K. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12927 · Cited by 22 · see citing works

Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology

Ando, T., Suzuki‐Karasaki, M., Suzuki‐Karasaki, M., Ichikawa, J., Ochiai, T., Yoshida, Y., Haro, H., & Suzuki‐Karasaki, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.593127 · Cited by 22 · see citing works

Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases

Qu, J., Ouyang, Z., Wu, W., Li, G., Wang, J., Lu, Q., & Li, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00534 · Cited by 21 · see citing works

DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development

Pires, S. F., de Barros, J. S., da Costa, S. S., Scliar, M. O., Lengert, A. V. H., Boldrini, É., da Silva, S. R. M., Tasić, L., Vidal, D. O., Krepischi, A. C. V., et al. (2023) · Molecular Genetics and Genomics · doi:10.1007/s00438-023-02010-8 · Cited by 21 · see citing works

Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma

Luo, Y., Zeng, A., Fang, A., Song, L., Fan, C., Zeng, C., Ye, T., Chen, H., Tu, C., & Xie, Y. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00724-4 · Cited by 21 · see citing works

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells

Li, J., Wang, R., Qin, J., Zeng, H., Wang, K., He, Q., Wang, D., & Wang, S. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.43506 · Cited by 21 · see citing works

Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway

Saba, K. H., Difilippo, V., Kovac, M. B., Cornmark, L., Magnusson, L., Nilsson, J., van den Bos, H., Spierings, D. C. J., Bidgoli, M., Jonson, T., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6219 · Cited by 20 · see citing works

Chromatin Mechanisms Driving CancerPreprint

Gryder, B. E., Scacheri, P. C., Ried, T., & Khan, J. I. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040956 · Cited by 19 · see citing works

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Lizardo, M. M., & Sorensen, P. H. (2018) · Journal of Visualized Experiments · doi:10.3791/56332 · Cited by 19 · see citing works

Ultra-pH-sensitive nanoplatform for precise tumor therapy

Zhang, K., Li, S., Li, J., Zhou, X., Qin, Y., Wu, L., & Ling, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122858 · Cited by 19 · see citing works

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma

Jubelin, C., Muñoz-García, J., Cochonneau, D., Moranton, E., Heymann, M., & Heymann, D. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.130 · Cited by 19 · see citing works

Children's Oncology Group's 2023 blueprint for research: Bone tumors

Reed, D. R., Grohar, P. J., Rubin, E. M., Binitie, O. T., Krailo, M., Davis, J. L., DuBois, S. G., & Janeway, K. A. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30583 · Cited by 20 · see citing works

Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory

Michelatti, D., Beyes, S., Bernardis, C., Negri, M. L., Morelli, L., Bediaga, N. G., Poli, V., Fagnocchi, L., Lago, S., D’Annunzio, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46524-0 · Cited by 19 · see citing works

Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose

Corradin, O., Sallari, R. C., Hoang, A. T., Kassim, B. S., Hutta, G. B., Cuoto, L., Quach, B. C., Lovrenert, K., Hays, C., Gryder, B. E., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01477-y · Cited by 17 · see citing works

Blood coagulation and cancer genes

Tawil, N., & Rak, J. W. (2022) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2022.101349 · Cited by 18 · see citing works

ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis

Wang, R., Bhatt, A. B., Minden‐Birkenmaier, B. A., Travis, O. K., Tiwari, S., Jia, H., Rosikiewicz, W., Martinot, O., Childs, E., Loesch, R., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq3951 · Cited by 18 · see citing works

Direct contact between tumor cells and platelets initiates a FAK-dependent F3/TGF-β positive feedback loop that promotes tumor progression and EMT in osteosarcoma

Shi, Q., Xu, J., Chen, C., Hu, X., Wang, B., Zeng, F., Ren, T., Huang, Y., Guo, W., Tang, X., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216902 · Cited by 18 · see citing works

Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis

Lizardo, M. M., Hughes, C. S., Huang, Y. Z., Shyp, T., Delaidelli, A., Zhang, H., Shaool, S. S., Renner, A. F., Burwag, F., Sayles, L. C., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1317 · Cited by 18 · see citing works

Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force

Whittle, S. B., Offer, K., Roberts, R. D., LeBlanc, A. K., London, C. A., Majzner, R. G., Huang, A. Y.-C., Houghton, P. J., Sweet-Cordero, A., Grohar, P. J., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29188 · Cited by 18 · see citing works

Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition

Capobianco, E., McGaughey, V., Seraphin, G., Heckel, J. E., Rieger, S., & Lisse, T. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1188641 · Cited by 17 · see citing works

Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development

Pires, S. F., de Barros, J. S., da Costa, S. S., do Carmo, G. B., Scliar, M. O., Lengert, A. V. H., Boldrini, É., da Silva, S. R. M., Vidal, D. O., Maschietto, M. C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310463 · Cited by 16 · see citing works

Global Regulatory DNA Potentiation by SMARCA4 Propagates to Selective Gene Expression Programs via Domain-Level Remodeling.

Lazar, J., Stehling-Sun, S., Nandakumar, V., Wang, H., Chee, D. R., Howard, N. P., Acosta, R., Dunn, D., Diegel, M., Neri, F. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107676 · Cited by 11 · see citing works

The genetic script of metastasis

Jinesh, G. G., & Brohl, A. S. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12562 · Cited by 16 · see citing works

KMT2C modulates migration and invasion processes in osteosarcoma cell lines

Chiappetta, C., Carletti, R., Rocca, C. D., & Cristofano, C. D. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152534 · Cited by 15 · see citing works

Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis

Pontius, W., Hong, E. S., Faber, Z. J., Gray, J., Peacock, C. D., Bayles, I., Lovrenert, K., Chin, D. H., Gryder, B. E., Bartels, C. F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42656-x · Cited by 14 · see citing works

Air Plasma-Activated Medium Evokes a Death-Associated Perinuclear Mitochondrial Clustering

Suzuki‐Karasaki, M., Ando, T., Ochiai, Y., Kawahara, K., Suzuki‐Karasaki, M., Nakayama, H., & Suzuki‐Karasaki, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031124 · Cited by 14 · see citing works

Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas

Wood, G. E., Graves, L. A., Rubin, E. M., Reed, D. R., Riedel, R. F., & Strauss, S. J. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_390306 · Cited by 14 · see citing works

Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis

Nerlakanti, N., McGuire, J., Bishop, R. T., Nasr, M. M., Li, T., Reed, D. R., & Lynch, C. C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217302 · Cited by 14 · see citing works

Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy

Liu, Y., Lin, Y., Liao, S., Feng, W., Liu, J., Luo, X., Wei, Q., & Tang, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23601 · Cited by 12 · see citing works

Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients

Lin, Y., Tang, H., Teng, H., Feng, W., Li, F., Liu, S., Liu, Y., & Wei, Q. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111364 · Cited by 12 · see citing works

Oleanolic acid inhibits osteosarcoma cell proliferation and invasion by suppressing the SOX9/Wnt1 signaling pathway

Chen, X., Zhang, Y., Zhang, S., Wang, A., Du, Q., & Wang, Z. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9883 · Cited by 12 · see citing works

Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization

McAloney, C. A., Makkawi, R., Budhathoki, Y., Cannon, M. V., Franz, E., Gross, A. C., Cam, M., Vetter, T. A., Duhen, R., Davies, A. E., et al. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00867-w · Cited by 12 · see citing works

Vitamin C enhances the sensitivity of osteosarcoma to arsenic trioxide via inhibiting aerobic glycolysis

Liu, Y., Yue, J., Ren, Z., He, M., Wang, A., Xie, J., Li, T., Liu, G., He, X., Ge, S., et al. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116798 · Cited by 11 · see citing works

Aberrant EZHIP expression drives tumorigenesis in osteosarcoma

Jawhar, W., Danieau, G., Annett, A., Ishii, T., Bajic, A., Castillo-Orozco, A., Krug, B., Faucher-Jabado, Y., Seyedmoomenkashi, J., Saquib, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61558-8 · Cited by 11 · see citing works

11-O-Galloyl Bergenin from Corylopsis coreanas Leaves Induces Autophagy and Apoptosis in Human Osteosarcoma

Park, K., Kwon, Y.-J., Cho, M., Kwon, I. K., Hong, J. T., & Yun, H. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500956 · Cited by 11 · see citing works

Intrinsic Epigenetic State of Primary Osteosarcoma Drives Metastasis

Singh, I., Rainusso, N. C., Kurenbekova, L., Nirala, B. K., Dou, J., Muruganandham, A., & Yustein, J. T. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0055 · Cited by 9 · see citing works

POLE2 promotes osteosarcoma progression by enhancing the stability of CD44

Wang, B., Hu, H., Wang, X. M., Shao, Z., Shi, D., Wu, F., Liu, J., Zhang, Z., Li, J., Xia, Z., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01875-x · Cited by 9 · see citing works

Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma

Torres, H. M., VanCleave, A. M., Vollmer, M. L., Callahan, D., Smithback, A., Conn, J. M., Rodezno, T. G., Gao, Z., Cao, Y. X., Tecleab, Y. A., et al. (2021) · Cancers · doi:10.3390/cancers13164199 · Cited by 9 · see citing works

Superenhancers activate the autophagy-related genes Beclin1 and LC3B to drive metastasis and drug resistance in osteosarcoma

Wang, H., Liu, Z., Wang, J., Hu, F., Zhou, Q., Wei, L., Bao, Q., Liang, J., Liang, J., Liu, Z., et al. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0919-0 · Cited by 9 · see citing works

Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms

Li, G., Lei, J., Xu, D., Yu, W., Bai, J., & Wu, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-33009-1 · Cited by 9 · see citing works

Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy

Welch, D. L., Fridley, B. L., Cen, L., Teer, J. K., Yoder, S., Pettersson, F. H., Xu, L., Cheng, C., Zhang, Y., Alexandrow, M. G., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47412-1 · Cited by 8 · see citing works

Controlled domain gels with a wide stiffness gradient simultaneously promote bone regeneration and suppress tumor recurrence through DAPK activity

Wang, Y., Zhang, J., Shu, X., Wu, F., & He, J. H. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149018 · Cited by 8 · see citing works

Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma

Wang, H., Tao, Y., Han, J., Shen, J., Mu, H., Wang, Z., Wang, J., Jin, X., Zhang, Q., Yang, Y., et al. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00967-1 · Cited by 9 · see citing works

Selective enhancer changes in osteosarcoma lung metastasis

Kovar, H. (2018) · Nature Medicine · doi:10.1038/nm.4487 · Cited by 8 · see citing works

Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma

Collier, C. D., Getty, P. J., & Greenfield, E. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_4 · Cited by 8 · see citing works

Positively Selected Enhancer Elements Endow Tumor Cells with Metastatic CompetencePreprint

Morrow, J. J., Bayles, I., Funnell, A. P. W., Miller, T. E., Saiakhova, A., Lizardo, M. M., Bartels, C. F., Kapteijn, M. Y., Hung, S., Mendoza, A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/155416 · Cited by 1 · see citing works

Abstract LB-151: Positively selected enhancer elements endow tumor cells with metastatic competence

Morrow, J. J., Miller, T. E., Saiakhova, A., Lizardo, M. M., Bartels, C. F., Bayles, I., Hung, S., Mendoza, A., Myers, J., Allen, F., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-lb-151

Enhancer-Driven Gene Expression Changes Facilitate Metastasis

(2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2018-015

Abstract 6325: Identification of genes responsible for osteosarcomas metastatic evolution by active super enhancers profiling

Lavaud, M., Tesfaye, R. A., Charrier, C., Thépault, R., Golias, M., Page, S. L., Mullard, M., Royer, B. B.-L., Verrecchia, F., Baud’huin, M., et al. (2022) · Cancer Research · doi:10.1158/1538-7445.am2022-6325

Selective enhancer changes in osteosarcoma lung metastasis

Kovar, H. (2018) · Nature Medicine · doi:10.1038/nm.4487 · Cited by 8 · see citing works